← FDA Drug Approvals (Drugs@FDA)

BIMATOPROST

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: GLAND · Approved 2019-03-22

Drug application

FDA Application #

ANDA210126

Application type

Abbreviated New Drug Application (Generic)

Brand name

BIMATOPROST

Generic name

BIMATOPROST

Active ingredients

BIMATOPROST

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

GLAND

Manufacturer

Fosun Pharma USA Inc.

First approval

2019-03-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown